BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24386344)

  • 1. Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
    Fjær S; Bø L; Lundervold A; Myhr KM; Pavlin T; Torkildsen O; Wergeland S
    PLoS One; 2013; 8(12):e84162. PubMed ID: 24386344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
    Tagge I; O'Connor A; Chaudhary P; Pollaro J; Berlow Y; Chalupsky M; Bourdette D; Woltjer R; Johnson M; Rooney W
    PLoS One; 2016; 11(4):e0152480. PubMed ID: 27054832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.
    Guglielmetti C; Boucneau T; Cao P; Van der Linden A; Larson PEZ; Chaumeil MM
    Neuroimage; 2020 Mar; 208():116415. PubMed ID: 31811900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
    Thiessen JD; Zhang Y; Zhang H; Wang L; Buist R; Del Bigio MR; Kong J; Li XM; Martin M
    NMR Biomed; 2013 Nov; 26(11):1562-81. PubMed ID: 23943390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
    Goldberg J; Clarner T; Beyer C; Kipp M
    J Mol Neurosci; 2015 Oct; 57(2):166-75. PubMed ID: 26067430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model.
    Khodanovich MY; Sorokina IV; Glazacheva VY; Akulov AE; Nemirovich-Danchenko NM; Romashchenko AV; Tolstikova TG; Mustafina LR; Yarnykh VL
    Sci Rep; 2017 Apr; 7():46686. PubMed ID: 28436460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.
    Fjær S; Bø L; Myhr KM; Torkildsen Ø; Wergeland S
    Neurochem Int; 2015; 83-84():28-40. PubMed ID: 25744931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.
    Baxi EG; DeBruin J; Jin J; Strasburger HJ; Smith MD; Orthmann-Murphy JL; Schott JT; Fairchild AN; Bergles DE; Calabresi PA
    Glia; 2017 Dec; 65(12):2087-2098. PubMed ID: 28940645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
    Guglielmetti C; Veraart J; Roelant E; Mai Z; Daans J; Van Audekerke J; Naeyaert M; Vanhoutte G; Delgado Y Palacios R; Praet J; Fieremans E; Ponsaerts P; Sijbers J; Van der Linden A; Verhoye M
    Neuroimage; 2016 Jan; 125():363-377. PubMed ID: 26525654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological changes in mice with long term cuprizone administration.
    Nomura T; Bando Y; Nakazawa H; Kanemoto S; Yoshida S
    Neurochem Int; 2019 Jun; 126():229-238. PubMed ID: 30940543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
    Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
    Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
    Azami Tameh A; Clarner T; Beyer C; Atlasi MA; Hassanzadeh G; Naderian H
    Ann Anat; 2013 Oct; 195(5):415-23. PubMed ID: 23711509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
    Praet J; Orije J; Kara F; Guglielmetti C; Santermans E; Daans J; Hens N; Verhoye M; Berneman Z; Ponsaerts P; Van der Linden A
    NMR Biomed; 2015 Apr; 28(4):505-13. PubMed ID: 25802215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice.
    Bölcskei K; Kriszta G; Sághy É; Payrits M; Sipos É; Vranesics A; Berente Z; Ábrahám H; Ács P; Komoly S; Pintér E
    J Neuroimmunol; 2018 Jul; 320():1-10. PubMed ID: 29759134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhomogeneous Magnetization Transfer (ihMT) imaging in the acute cuprizone mouse model of demyelination/remyelination.
    Hertanu A; Soustelle L; Buron J; Le Priellec J; Cayre M; Le Troter A; Prevost VH; Ranjeva JP; Varma G; Alsop DC; Durbec P; Girard OM; Duhamel G
    Neuroimage; 2023 Jan; 265():119785. PubMed ID: 36464096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction.
    Khodanovich M; Pishchelko A; Glazacheva V; Pan E; Akulov A; Svetlik M; Tyumentseva Y; Anan'ina T; Yarnykh V
    Cells; 2019 Oct; 8(10):. PubMed ID: 31590363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated analysis of gray matter damage in aged mice reveals impaired remyelination in the cuprizone model.
    Gingele S; Möllenkamp TM; Henkel F; Schröder LJ; Hümmert MW; Skripuletz T; Stangel M; Gudi V
    Brain Pathol; 2024 Mar; 34(2):e13218. PubMed ID: 37927164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T.
    Zaaraoui W; Deloire M; Merle M; Girard C; Raffard G; Biran M; Inglese M; Petry KG; Gonen O; Brochet B; Franconi JM; Dousset V
    MAGMA; 2008 Sep; 21(5):357-62. PubMed ID: 18779984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.
    Janssen K; Rickert M; Clarner T; Beyer C; Kipp M
    Mol Neurobiol; 2016 Apr; 53(3):1551-1564. PubMed ID: 25663168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.